Martin E. Cearnal - Dec 1, 2021 Form 4 Insider Report for CUMBERLAND PHARMACEUTICALS INC (CPIX)

Role
Sr VP/Chief Commercial Officer, Director
Signature
Martin E. Cearnal by /s/ John Hamm as attorney-in-fact
Stock symbol
CPIX
Transactions as of
Dec 1, 2021
Transactions value $
$9,571
Form type
4
Date filed
1/7/2022, 04:07 PM
Previous filing
Dec 3, 2021
Next filing
Apr 29, 2022

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction CPIX Common Stock Purchase $373 +90 +0.05% $4.14 176K Dec 1, 2021 Direct F1
transaction CPIX Common Stock Purchase $346 +90 +0.05% $3.84 177K Dec 2, 2021 Direct F1
transaction CPIX Common Stock Purchase $402 +90 +0.05% $4.47 177K Dec 3, 2021 Direct F1
transaction CPIX Common Stock Purchase $401 +90 +0.05% $4.46 177K Dec 6, 2021 Direct F1
transaction CPIX Common Stock Purchase $505 +90 +0.05% $5.61 177K Dec 7, 2021 Direct F1
transaction CPIX Common Stock Purchase $554 +90 +0.05% $6.15 177K Dec 8, 2021 Direct F1
transaction CPIX Common Stock Purchase $523 +90 +0.05% $5.81 177K Dec 9, 2021 Direct F1
transaction CPIX Common Stock Purchase $434 +90 +0.05% $4.82 177K Dec 10, 2021 Direct F1
transaction CPIX Common Stock Purchase $872 +200 +0.11% $4.36 177K Dec 13, 2021 Direct F1
transaction CPIX Common Stock Purchase $856 +200 +0.11% $4.28 177K Dec 14, 2021 Direct F1
transaction CPIX Common Stock Purchase $858 +200 +0.11% $4.29 178K Dec 15, 2021 Direct F1
transaction CPIX Common Stock Purchase $1.09K +240 +0.14% $4.53 178K Dec 16, 2021 Direct F1
transaction CPIX Common Stock Purchase $1K +240 +0.13% $4.17 178K Dec 17, 2021 Direct F1
transaction CPIX Common Stock Purchase $1.36K +314 +0.18% $4.33 178K Dec 20, 2021 Direct F1
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 The purchases reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person during March 2021.